Electromyography (EMG) is used to test the electrical activities of muscle fibres and nerve cells dysfunction. The test can be recorded by Needle Electrodes during period of muscle rest and muscle contraction. Small needles are inserted into skin through muscle. The activity of dysfunction can be heard by audio-amplifier. This is basically used for neuromuscular disorders. Electrical signals can not be produced during the period of muscle rest if muscle is healthy but when electrode is inserted it can produce brief activity which can be recorded by oscilloscope. The test can diagnose several nerve disorders like polymyositis, numbness, cramping, tingling, carpal tunnel syndrome, amyotrophic lateral sclerosis, myasthenia gravis etc.

The major driving factor of this market is increasing neurophysiology devices. Increasing research activities in neurology and cerebral disorders have accelerated the market growth. Technology advancement and improving treatment techniques are other factors for the growth of this market. There is low risk in this procedure. Though infection, eternal bleeding can be happened during the insertion of needle electrode. Discomforts and pain may be caused to patients during the test. Some medical condition such as installed pacemaker in body, blood thinning medication or Haemophilia can hamper to deliver accurate result of the test. This test should be solely prescribed by neurological consultant. Electromyography now majorly used in sports medicine. This test is also growing in case of Alzheimer’s and Parkinson’s disease. This test is used to detect, treat and manage the diseases. The major restraints of this market are lack of awareness and lack of skilled professional. Low Government Investment also can hinder this market.

The key players of this market are Masimo Corporation, Electrical Geodesics Inc., Covidien Limited, Nihon Kohden America Inc., Natus Medical Inc., SparkFun Electronics, Medtronic Plc., Zynex Inc., Allengers Medical Systems, NeuroWave Systems Inc., Cadwell Laboratories Inc.

The Middle East Electromyography Market has been segmented on the basis of modality, types of products, application and key geographies. The research report “Middle East Electromyography Market” provides in-depth analysis of Middle East Electromyography market based on modality, types of products, application and major geographies for the forecast period from 2018 to 2024. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the Middle East Electromyography market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace is Electromyography market growing? What will be growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the Electromyography?
4- What are the various application areas and how they are poised to grow?

Market Segments:
• By Modality
o Stationary Device
o Portable Device

• By Type of Products
o Surface EMG
o Intramuscular EMG

• By Application
o Healthcare
o Hospital
o Household
o Sleep Laboratories
o Ambulatory surgical centres

• By Geography
o Middle East
• GCC Countries
• Saudi Arabia
• United Arab Emirates
• Qatar
• Kuwait
• Oman
• Bahrein
• Egypt
• Israel
• Turkey

Leading Market Players:
• Masimo Corporation
• Electrical Geodesics Inc.
• Covidien Limited
• Noraxon U.S.A., Inc.
• Nihon Kohden America Inc.
• Natus Medical Inc.
• SparkFun Electronics
• Medtronic Plc
• Allengers Medical Systems
• Zynex Inc.

*Other prominent players in the market which can be profiled as a part of customization:
• NeuroWave Systems Inc.
• Cadwell Laboratories Inc.